Pharmacology · 2007 · 75 citations · 35 references
Life SciencesCancer BiologyOncologyApoptosisGene ExpressionMolecular OncologyApoptosis In CancerApoptosis ModulationApoptosis RegulationApoptosis ResistanceApoptotic SignalingIntrinsic Apoptotic PathwayAnnexin V AssaysAnticancer ActivityCancer Cell ApoptosisP53 InactivationP53-mediated ApoptosisP53-mediated Cell DeathProtein Translation ControlTumor Suppressor P53
BACKGROUND AND PURPOSE: Trans-resveratrol (RSVL; 3,4',5-trihydroxystilbene), a natural compound found in grapes, berries, peanuts and red wine exerts certain anticancer roles in different human cancer types. However, the exact molecular mechanism(s) behind such a role remains to be elucidated, thus the aim of this study. EXPERIMENTAL APPROACH: T47D human breast cancer cells were treated with RSVL and cell proliferation was measured by cell counting. Apoptosis was analyzed by Giemsa staining, poly(ADP-ribose) polymerase (PARP) fragmentation analysis and annexin V assay. Regulation of p53 tumor suppressor protein, p70S6K, and pS6 ribosomal protein was measured by detecting their phosphorylated active forms using ECL-immunoblot analysis. RESULTS: The present results show that RSVL-induced growth inhibition in T47D cells is caused by apoptosis as demonstrated by morphological changes and PARP fragmentation. RSVL-induced apoptosis is associated with the activation of the p53 in a dose- and a time-dependent manner. Phosphatidylinositol 3-kinase (PI3K) inhibitors, wortmannin and LY294002 abolished the effect of RSVL on p53 activation. Interestingly, RSVL inhibits the expression of p70S6K and the phosphorylation of pS6RP. CONCLUSIONS AND IMPLICATIONS: These findings demonstrate that RSVL affects multiple intracellular signaling transduction pathways such as p53 activation/protein translation inhibition/apoptosis, and strongly support a contemplated use of this natural compound as a preventive and/or an adjuvant therapeutic drug for breast cancer. The data indicate that these proteins may be used as predictive biomarkers to evaluate the treatment efficacy of RSVL in clinical trials.
35
WAF1, a potential mediator of p53 tumor suppression
Wafik S. El‐Deiry, Takashi Tokino, Victor E. Velculescu et al. · Cell · 1993 · 8.4K citations
Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes
Meishiang Jang, Lining Cai, George Udeani et al. · Science · 1997 · 4.9K citations
Medicine, Oncology, Pharmacology +17
DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2
Sheau-Yann Shieh, Masako Ikeda, Yoichi Taya et al. · Cell · 1997 · 2.1K citations · Full text